Literature DB >> 9817494

Usefulness of pindolol in neurocardiogenic syncope.

D Iskos1, J Dutton, M M Scheinman, K G Lurie.   

Abstract

We prospectively studied the efficacy of pindolol, a beta-adrenergic blocker with intrinsic sympathomimetic activity (ISA), for the prevention of syncope recurrences in 31 patients with recurrent neurocardiogenic syncope. Pindolol proved to be an effective treatment, even in patients who had previously failed treatment with conventional beta blockers, suggesting a clinical benefit from addition of ISA to beta blockade in this setting.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9817494     DOI： 10.1016/s0002-9149(98)00568-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Neurally mediated syncope.

Authors:  M Zaqqa; A Massumi
Journal:  Tex Heart Inst J       Date:  2000

2.  Neurally Mediated Syncope.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-08

3.  [Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].

Authors:  K Seidl; A Schuchert; J Tebbenjohanns; W Hartung
Journal:  Z Kardiol       Date:  2005-09

4.  Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.

Authors:  Martin D Lowe; James A Lynham; Andrew A Grace; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 5.  Neurocardiogenic syncope: aetiology and management.

Authors:  K A Gatzoulis; P K Toutouzas
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  Non-invasive management of vasovagal syncope.

Authors:  Samuel T Coffin; Satish R Raj
Journal:  Auton Neurosci       Date:  2014-06-21       Impact factor: 3.145

Review 7.  Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hypotension.

Authors:  Satish R Raj; Samuel T Coffin
Journal:  Prog Cardiovasc Dis       Date:  2013 Jan-Feb       Impact factor: 8.194

8.  Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.

Authors:  Shirin S Joseph; James A Lynham; Peter Molenaar; Andrew A Grace; William H Colledge; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-08       Impact factor: 3.000

Review 9.  New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope.

Authors:  Daniel P Melby; Joseph A Cytron; David G Benditt
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

10.  Syncope.

Authors:  Pamela Nerheim; Brian Olshansky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.